NGNE Neurogene Inc. logo

NGNE Neurogene Inc.

Healthcare
$27.10-2.20%ClosedMarket Cap: $428.2M

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

1

Dispositions

2

Buy/Sell Ratio

0.50

Net Shares

+110,400

Shares Acquired

120,000

Shares Disposed

9,600

Total Bought ($)

$0.00

Total Sold ($)

$2.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri May 08Cvijic Christine Mikaildirector, officer: President and CFOSell4,800$30.0798,440
Thu May 07Shafer Christinaofficer: Chief Commercial OfficerSell120,000$28.94120,000
Mon Apr 20Shafer ChristinaofficerSell0$0.000
Mon Mar 30McMinn Racheldirector, officer: Chief Executive OfficerSell3,352$22.071,344,307
Mon Mar 30Jordan Julieofficer: Chief Medical OfficerSell828$21.8912,472
Mon Mar 30Cvijic Christine Mikailofficer: President and CFOSell2,558$21.62103,240
Tue Mar 17Cvijic Christine Mikailofficer: President and CFOSell2,387$20.42107,456
Tue Mar 17Cvijic Christine Mikailofficer: President and CFOSell1,395$21.25106,061
Tue Mar 17Cvijic Christine Mikailofficer: President and CFOSell263$22.02105,798
Tue Mar 17Cobb Stuartofficer: Chief Scientific OfficerSell3,991$20.4133,303
Tue Mar 17Cobb Stuartofficer: Chief Scientific OfficerSell2,658$21.3430,645
Tue Mar 17Cobb Stuartofficer: Chief Scientific OfficerSell148$22.0830,497
Tue Mar 03Cvijic Christine Mikailofficer: President and CFOSell4,800$25.11109,843
Tue Feb 24Jordan Julieofficer: Chief Medical OfficerSell29,600$17.6429,600
Tue Feb 24Jordan Julieofficer: Chief Medical OfficerSell4,900$0.0013,300